Trevi Therapeutics TRVI
NASDAQ TRVI
$12.83 +0.93 (+7.82%)
At close: Oct 20, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Total Non-Current Liabilities (2022)

Updated

Trevi Therapeutics (TRVI) posted Total Non-Current Liabilities of $15.55 million for Q4 2022, down 15.7% from the prior quarter.

Analysis

Trevi Therapeutics (TRVI) Total Non-Current Liabilities (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 105.50 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 106.45 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 33.91 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 35.10 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 97.04 Bn
10 Trevi Therapeutics 2.02 Bn 1.14 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 15.55 Mn
Sep 30, 2022 18.44 Mn
Jun 30, 2022 20.86 Mn
API Access

Trevi Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=TRVI&period=max&api_key=YOUR_API_KEY